Related Experiment Video
Updated: Aug 13, 2025

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Published on: January 5, 2016
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?
Matteo Augello1, Valeria Bono1, Roberta Rovito1
1Clinic of Infectious Diseases and Tropical Medicine, Department of Health Sciences, San Paolo Hospital, ASST Santi Paolo E Carlo, University of Milan, Via A. Di Rudinì, 8, 20142, Milan, Italy.
People with HIV (PLWH) may face worse COVID-19 outcomes and weaker immune responses to infection and vaccines, especially with uncontrolled HIV. Prioritizing vaccination and careful follow-up is crucial for this vulnerable group.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Background:
- HIV/AIDS and COVID-19 are major global pandemics.
- People living with HIV (PLWH) may have persistent immune dysfunction despite treatment.
- Concerns exist regarding increased COVID-19 severity and vaccine response in PLWH.
Purpose of the Study:
- To discuss the interaction between HIV and SARS-CoV-2.
- To focus on immune responses to SARS-CoV-2 infection and vaccination in PLWH.
Main Methods:
- Review of current literature on COVID-19 in PLWH.
- Analysis of immune responses to SARS-CoV-2 infection and vaccination.
- Assessment of COVID-19 outcomes and sequelae in PLWH.
Main Results:
- Worse COVID-19 outcomes and lower immune responses observed in PLWH with low CD4+ T-cell counts or uncontrolled HIV.
- Scarce data suggests a potentially higher incidence of post-acute sequelae of SARS-CoV-2 infection (PASC) in PLWH.
- Poor immunovirological control is linked to weak immune responses and adverse COVID-19 outcomes.
Conclusions:
- PLWH with poor immune control require prioritized vaccination and potentially additional doses.
- Enhanced and prolonged follow-up is recommended for PLWH after COVID-19 due to potential long-term risks.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Sexually Transmitted Infections
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Retrovirus Life Cycles

